Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials
Related Posts
Li YR, Li Z, Zhu Y, Li M, Chen Y, Lee D, Ochoa CJ, Singh T, DiBernardo G, Guo W, Li S, Zhou Y, Yu[...]
Patel R, Bartolo G, Castelletto ML, Garcia Romero A, Bryant AS, Agak GW, Hallem EA. Dopamine signaling drives skin invasion by human-infective nematodes. Nat Commun.[...]
Smith SE, Swanson LA, Wonnaparhown A, DiCaudo DJ, Nelson SA, Kasperkiewicz M. Delayed diagnosis of pemphigus herpetiformis in a patient with dupilumab-associated hypereosinophilia. JAAD Case[...]